Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults

Intern Med. 2023 Sep 1;62(17):2565-2569. doi: 10.2169/internalmedicine.1728-23. Epub 2023 Jun 14.

Abstract

Multisystem inflammatory syndrome in adults (MIS-A) is a life-threatening disease that can develop weeks after coronavirus disease 2019 (COVID-19). MIS-A symptoms include multiorgan involvement, especially gastrointestinal tract and heart involvement, and Kawasaki disease-like symptoms. We herein report a 44-year-old Japanese man with MIS-A who had contracted COVID-19 five weeks ago and went into shock after acute gastroenteritis, acute kidney injury, and Kawasaki disease-like symptoms. Methylprednisone pulse and high-dose intravenous immunoglobulin resulted in recovery of shock and his renal function, but diffuse ST-segment elevation on electrocardiography and pericardial effusion with a fever emerged after therapy. Additional granulocyte-monocyte adsorptive apheresis successfully ameliorated the cardiac involvement.

Keywords: COVID-19; MIS-A; granulocyte and monocyte adsorptive apheresis; multisystem inflammatory syndrome in adults; myocarditis; pericarditis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Component Removal*
  • COVID-19* / complications
  • COVID-19* / therapy
  • Connective Tissue Diseases*
  • Granulocytes
  • Humans
  • Male
  • Monocytes
  • Mucocutaneous Lymph Node Syndrome*
  • Systemic Inflammatory Response Syndrome / complications
  • Systemic Inflammatory Response Syndrome / therapy

Supplementary concepts

  • adult multisystem inflammatory disease, COVID-19 related